SRAX INC (SRAX) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:SRAX • US78472M1062

0.6 USD
-0.98 (-62.03%)
At close: Mar 8, 2023
0.62 USD
+0.02 (+3.33%)
After Hours: 3/8/2023, 8:07:58 PM
Fundamental Rating

3

Taking everything into account, SRAX scores 3 out of 10 in our fundamental rating. SRAX was compared to 278 industry peers in the Software industry. The financial health of SRAX is average, but there are quite some concerns on its profitability. SRAX has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • SRAX had negative earnings in the past year.
  • SRAX had a negative operating cash flow in the past year.
SRAX Yearly Net Income VS EBIT VS OCF VS FCFSRAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 -10M -20M -30M

1.2 Ratios

  • The profitability ratios for SRAX are negative, so there is not much use analyzing them.
  • With a decent Return On Invested Capital value of 0.04%, SRAX is doing good in the industry, outperforming 73.06% of the companies in the same industry.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 0.04%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SRAX Yearly ROA, ROE, ROICSRAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 50 -50 -100 -150 -200

1.3 Margins

  • With a decent Operating Margin value of 0.05%, SRAX is doing good in the industry, outperforming 73.06% of the companies in the same industry.
  • Looking at the Gross Margin, with a value of 73.34%, SRAX is in the better half of the industry, outperforming 70.03% of the companies in the same industry.
  • In the last couple of years the Gross Margin of SRAX has grown nicely.
Industry RankSector Rank
OM 0.05%
PM (TTM) N/A
GM 73.34%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.58%
GM growth 5Y16.6%
SRAX Yearly Profit, Operating, Gross MarginsSRAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 -100 -200 -300 -400

More info and screens

5

2. Health

2.1 Basic Checks

  • SRAX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for SRAX has been increased compared to 1 year ago.
  • Compared to 1 year ago, SRAX has an improved debt to assets ratio.
SRAX Yearly Shares OutstandingSRAX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 5M 10M 15M 20M 25M
SRAX Yearly Total Debt VS Total AssetsSRAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M

2.2 Solvency

  • SRAX has an Altman-Z score of 0.23. This is a bad value and indicates that SRAX is not financially healthy and even has some risk of bankruptcy.
  • SRAX has a worse Altman-Z score (0.23) than 67.00% of its industry peers.
  • SRAX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.23
ROIC/WACC0
WACC10.1%
SRAX Yearly LT Debt VS Equity VS FCFSRAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 10M -10M 20M -20M

2.3 Liquidity

  • SRAX has a Current Ratio of 1.13. This is a normal value and indicates that SRAX is financially healthy and should not expect problems in meeting its short term obligations.
  • SRAX has a worse Current ratio (1.13) than 71.72% of its industry peers.
  • A Quick Ratio of 1.13 indicates that SRAX should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.13, SRAX is not doing good in the industry: 71.04% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 1.13
SRAX Yearly Current Assets VS Current LiabilitesSRAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 5M 10M 15M 20M

More info and screens

3

3. Growth

3.1 Past

  • SRAX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 42.18%, which is quite impressive.
  • The Revenue has grown by 109.34% in the past year. This is a very strong growth!
  • Measured over the past years, SRAX shows a decrease in Revenue. The Revenue has been decreasing by -5.67% on average per year.
EPS 1Y (TTM)42.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%123.2%
Revenue 1Y (TTM)109.34%
Revenue growth 3Y39.3%
Revenue growth 5Y-5.67%
Sales Q2Q%37.85%

3.2 Future

  • The Earnings Per Share is expected to grow by 50.52% on average over the next years. This is a very strong growth
  • The Revenue is expected to decrease by -5.17% on average over the next years.
EPS Next Y124.58%
EPS Next 2Y50.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-7.07%
Revenue Next 2Y-5.17%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SRAX Yearly Revenue VS EstimatesSRAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
SRAX Yearly EPS VS EstimatesSRAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2020 2021 2022 2023 0 2 4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for SRAX. In the last year negative earnings were reported.
  • With a Price/Forward Earnings ratio of 1.95, the valuation of SRAX can be described as very cheap.
  • SRAX's Price/Forward Earnings ratio is rather cheap when compared to the industry. SRAX is cheaper than 100.00% of the companies in the same industry.
  • SRAX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.51.
Industry RankSector Rank
PE N/A
Fwd PE 1.95
SRAX Price Earnings VS Forward Price EarningsSRAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -65.27
SRAX Per share dataSRAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1

4.3 Compensation for Growth

  • SRAX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as SRAX's earnings are expected to grow with 50.52% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.52%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

  • SRAX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SRAX INC

NASDAQ:SRAX (3/8/2023, 8:07:58 PM)

After market: 0.62 +0.02 (+3.33%)

0.6

-0.98 (-62.03%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-02
Earnings (Next)04-03
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners9.92%
Ins Owner Change0%
Market Cap15.79M
Revenue(TTM)28.76M
Net Income(TTM)-19.94M
Analysts84.44
Price Target6.73 (1021.67%)
Short Float %0.63%
Short Ratio0.79
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-107.64%
Min EPS beat(2)-107.64%
Max EPS beat(2)-107.64%
EPS beat(4)0
Avg EPS beat(4)-1488.54%
Min EPS beat(4)-3627.65%
Max EPS beat(4)-107.64%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-35.89%
Min Revenue beat(2)-49.18%
Max Revenue beat(2)-22.6%
Revenue beat(4)1
Avg Revenue beat(4)-15.97%
Min Revenue beat(4)-49.18%
Max Revenue beat(4)9.08%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-24.72%
EPS NQ rev (1m)47.14%
EPS NQ rev (3m)-130.83%
EPS NY rev (1m)-20.14%
EPS NY rev (3m)-20.14%
Revenue NQ rev (1m)-19.15%
Revenue NQ rev (3m)-19.15%
Revenue NY rev (1m)-40.35%
Revenue NY rev (3m)-40.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1.95
P/S 0.55
P/FCF N/A
P/OCF N/A
P/B 0.64
P/tB 2.97
EV/EBITDA -65.27
EPS(TTM)-1.16
EYN/A
EPS(NY)0.31
Fwd EY51.34%
FCF(TTM)-0.89
FCFYN/A
OCF(TTM)-0.86
OCFYN/A
SpS1.09
BVpS0.94
TBVpS0.2
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC 0.04%
ROICexc N/A
ROICexgc N/A
OM 0.05%
PM (TTM) N/A
GM 73.34%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.58%
GM growth 5Y16.6%
F-Score4
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 1.6
Cap/Depr 127.87%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.13
Quick Ratio 1.13
Altman-Z 0.23
F-Score4
WACC10.1%
ROIC/WACC0
Cap/Depr(3y)101.84%
Cap/Depr(5y)118.99%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%123.2%
EPS Next Y124.58%
EPS Next 2Y50.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)109.34%
Revenue growth 3Y39.3%
Revenue growth 5Y-5.67%
Sales Q2Q%37.85%
Revenue Next Year-7.07%
Revenue Next 2Y-5.17%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y100.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year322.13%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-42.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-48.54%
OCF growth 3YN/A
OCF growth 5YN/A

SRAX INC / SRAX FAQ

What is the ChartMill fundamental rating of SRAX INC (SRAX) stock?

ChartMill assigns a fundamental rating of 3 / 10 to SRAX.


Can you provide the valuation status for SRAX INC?

ChartMill assigns a valuation rating of 7 / 10 to SRAX INC (SRAX). This can be considered as Undervalued.


What is the profitability of SRAX stock?

SRAX INC (SRAX) has a profitability rating of 1 / 10.


What is the financial health of SRAX INC (SRAX) stock?

The financial health rating of SRAX INC (SRAX) is 2 / 10.